X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-18 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $47.88 | -10,565 | 65,057 | -14% | -$505,856 | |||||
| M | 2025-03-18 | TARS | Neervannan Seshadri | COO | S - Sale | $47.89 | -7,583 | 79,682 | -9% | -$363,142 | |||||
| M | 2025-03-18 | TARS | Wahl Bryan | GC | S - Sale | $47.88 | -9,686 | 51,712 | -16% | -$463,766 | |||||
| M | 2025-03-18 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $47.88 | -6,711 | 46,355 | -13% | -$321,323 | |||||
| M | 2025-03-18 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $48.03 | -24,216 | 883,741 | -3% | -$1,163,050 | |||||
| M | 2025-03-18 | TARS | Farrow Jeffrey S | See Remarks | S - Sale | $47.88 | -3,724 | 22,431 | -14% | -$178,306 | |||||
2024-08-12 | TARS | Link William J Phd | Dir | S - Sale | $26.08 | -35,000 | 177,544 | -16% | -$912,961 | ||||||
| D | 2024-06-18 | TARS | Farrow Jeffrey S | See Remarks | S - Sale+OE | $27.47 | -10,445 | 18,136 | -37% | -$286,924 | |||||
| D | 2024-03-18 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale+OE | $30.60 | -4,766 | 54,075 | -8% | -$145,840 | |||||
| D | 2024-03-18 | TARS | Wahl Bryan | GC | S - Sale+OE | $30.60 | -4,436 | 40,951 | -10% | -$135,742 | |||||
| D | 2024-03-18 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale+OE | $30.60 | -10,415 | 856,562 | -1% | -$318,699 | |||||
| D | 2024-03-18 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $30.60 | -4,314 | 34,181 | -11% | -$132,008 | |||||
| D | 2024-03-18 | TARS | Neervannan Seshadri | COO | S - Sale+OE | $30.60 | -4,879 | 64,767 | -7% | -$149,297 | |||||
2023-12-27 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $20.22 | -8,000 | 838,703 | -1% | -$161,760 | ||||||
2023-12-20 | TARS | Trevejo Jose M. | CHIEF MEDICAL OFFICER | S - Sale | $20.00 | -2,252 | 2,251 | -50% | -$45,040 | ||||||
2023-12-20 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $20.27 | -40,000 | 846,703 | -5% | -$810,623 | ||||||
2023-12-15 | TARS | Goldberg Andrew D. | Dir | P - Purchase | $18.96 | +1,000 | 3,000 | +50% | +$18,960 | ||||||
| D | 2023-11-30 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $16.31 | -8,355 | 26,784 | -24% | -$136,270 | |||||
| D | 2023-11-30 | TARS | Wahl Bryan | GC | S - Sale+OE | $16.31 | -8,356 | 31,966 | -21% | -$136,286 | |||||
2023-11-15 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $18.37 | -8,000 | 886,703 | -1% | -$146,933 | ||||||
2023-10-18 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $13.24 | -8,000 | 894,703 | -1% | -$105,920 | ||||||
2023-10-05 | TARS | Trevejo Jose M. | CHIEF MEDICAL OFFICER | S - Sale | $18.00 | -1,604 | 4,503 | -26% | -$28,872 | ||||||
2023-09-20 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $17.21 | -8,000 | 902,703 | -1% | -$137,680 | ||||||
2023-08-23 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $17.23 | -8,000 | 910,703 | -1% | -$137,840 | ||||||
2023-08-15 | TARS | Lin Elizabeth Yeu | Dir | P - Purchase | $16.80 | +9,506 | 29,906 | +47% | +$159,701 | ||||||
2023-07-19 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $20.05 | -2,400 | 45,806 | -5% | -$48,120 | ||||||
2023-07-19 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $20.01 | -103,900 | 918,703 | -10% | -$2,078,984 | ||||||
2023-07-12 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $17.35 | -9,000 | 1,022,603 | -1% | -$156,150 | ||||||
2023-06-21 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $18.63 | -8,000 | 1,031,603 | -1% | -$149,040 | ||||||
2023-06-14 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $18.58 | -9,000 | 1,039,603 | -1% | -$167,220 | ||||||
2023-06-08 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $20.01 | -3,100 | 1,041,756 | 0% | -$62,031 | ||||||
2023-06-08 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $20.00 | -100 | 48,086 | 0% | -$2,000 | ||||||
| M | 2023-06-06 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $19.00 | -4,643 | 48,186 | -9% | -$88,231 | |||||
2023-05-17 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.90 | -8,000 | 1,051,703 | -1% | -$127,200 | ||||||
2023-05-10 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $16.80 | -9,000 | 1,059,703 | -1% | -$151,200 | ||||||
| M | 2023-04-28 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.11 | -10,119 | 1,068,703 | -1% | -$152,925 | |||||
2023-04-21 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.03 | -2,311 | 1,078,822 | 0% | -$34,734 | ||||||
2023-04-20 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.02 | -5,000 | 26,785 | -16% | -$70,100 | ||||||
2023-04-19 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $13.60 | -8,000 | 1,081,133 | -1% | -$108,800 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |